Biogen wins Euro MS approval, but loses patents. [electronic resource]
Producer: 19970807Description: 410 p. digitalISSN:- 1087-0156
- Adjuvants, Immunologic -- therapeutic use
- Biotechnology -- economics
- Drug Industry -- economics
- European Union
- Glatiramer Acetate
- Humans
- Immunosuppressive Agents -- therapeutic use
- Interferon beta-1a
- Interferon beta-1b
- Interferon-beta -- therapeutic use
- Israel
- Multiple Sclerosis -- therapy
- Patents as Topic -- legislation & jurisprudence
- Peptides -- economics
- Polymers
- Recombinant Proteins -- therapeutic use
- United States
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.